Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionDeutsche Bank Ag\
Latest Disclosed Ownership365,345 shares
Latest Disclosed Value $ 48,130,550
Deutsche Bank Ag\ ownership in NBIX / Neurocrine Biosciences, Inc.

On May 6, 2026 - Deutsche Bank Ag\ filed a 13F-HR form disclosing ownership of 365,345 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $48,130,550 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 367,944 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -0.71% during the quarter.

Deutsche Bank Ag\ has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 365,345 -2,599 -0.71 48,131 -7.77 0.0031
2026-02-11 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 367,944 -82,860 -18.38 52,185 -17.54 0.0170
2025-11-13 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 450,804 40,826 9.96 63,284 22.81 0.0212
2025-08-12 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 409,978 -16,956 -3.97 51,530 9.13 0.0190
2025-05-09 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 426,934 -34,848 -7.55 47,219 -25.09 0.0187
2025-06-30 2024-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 461,782 23,951 5.47 63,033 24.95 0.0247
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 461,782 23,951 63,033 0.0246
2025-06-26 2024-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 437,831 4,724 1.09 50,447 -15.39 0.0205
2024-11-13 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 437,831 4,724 50,447 0.0205
2025-06-12 2024-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 433,107 73,251 20.36 59,626 20.14 0.0269
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 433,107 73,251 59,626 0.0269
2025-06-02 2024-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 359,856 22,780 6.76 49,631 11.75 0.0230
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 359,856 22,780 49,631 0.0230
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 337,076 59,776 21.56 44,413 42.37 0.0227
2023-11-24 2023-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 277,300 -80,189 -22.43 31,196 -7.46 0.0201
2023-11-09 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 277,300 -80,189 31,196 0.0173
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 357,489 17,284 5.08 33,711 -2.10 0.0179
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 340,205 -345,315 -50.37 34,436 -57.94 0.0192
2023-02-13 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 685,520 269,065 64.61 81,879 85.11 0.0471
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 416,455 -30,979 -6.92 44,231 1.41 0.0267
2022-08-11 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 447,434 33,960 8.21 43,616 12.52 0.0243
2022-05-13 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 413,474 471 0.11 38,764 10.20 0.0181
2022-02-16 2021-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 413,003 -16,655 -3.88 35,175 -14.64 0.0158
2022-02-11 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 413,003 -16,655 35,175 0.0158
2021-11-04 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 429,658 2,455 0.57 41,208 -0.89 0.0195
2021-08-11 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 427,203 -61,403 -12.57 41,576 -12.50 0.0202
2021-05-13 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 488,606 49,521 11.28 47,517 12.90 0.0256
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 439,085 -69,910 -13.73 42,086 -14.02 0.0257
2020-11-12 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 508,995 -393,169 -43.58 48,946 -55.53 0.0337
2020-08-13 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 902,164 29,917 3.43 110,063 45.79 0.0837
2020-05-14 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 872,247 -109,243 -11.13 75,493 -28.44 0.0674
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 981,490 86,768 9.70 105,498 30.86 0.0687
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 894,722 -9,419 -1.04 80,621 5.62 0.0560
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 904,141 -120,494 -11.76 76,334 -15.44 0.0448
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,024,635 189,878 22.75 90,267 51.44 0.0537
2019-04-01 2018-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 834,757 -92,095 -9.94 59,607 -47.69 0.0423
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 834,757 43,907 59,607
2021-12-21 2018-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 926,852 142,723 18.20 113,957 47.93 0.0576
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 790,850 6,721 97,233 0.0672
2020-04-21 2018-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 784,129 -212,814 -21.35 77,032 -6.82 0.0384
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 691,948 -304,995 67,975 45,148.8256
2019-10-23 2018-03-31 13F/A-2 NEUROCRINE BIOSCIENCES COM 64125C109 996,943 28,738 2.97 82,674 10.06 0.0395
2019-10-18 2018-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 996,943 0 82,674 0.0395
2018-05-15 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 887,113 -81,092 73,565
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 968,205 -480,975 -33.19 75,119 -15.41 0.0481
2017-11-14 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,449,180 590,160 68.70 88,802 124.75 0.0608
2017-08-11 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 859,020 -28,714 -3.23 39,512 2.80 0.0282
2017-05-15 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 887,734 39,549 4.66 38,435 17.10 0.0284
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 848,185 -175,010 -17.10 32,822 -36.65 0.0264
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,023,195 -239,896 -18.99 51,813 -9.74 0.0367
2016-08-15 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,263,091 354,316 38.99 57,405 59.73 0.0405
2016-05-16 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 908,775 -58,416 -6.04 35,939 -34.31 0.0271
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 967,191 -68,327 -6.60 54,711 32.79 0.0379
2015-11-17 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,035,518 31,591 3.15 41,200 -14.07 0.0318
2015-08-12 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,003,927 -49,647 -4.71 47,946 14.61 0.0306
2015-05-15 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,053,574 47,153 4.69 41,835 86.08 0.0260
2015-02-13 2014-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,006,421 53,051 5.56 22,482 50.50 0.0139
2014-11-14 2014-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 953,370 111,004 13.18 14,938 19.55 0.0093
2014-08-15 2014-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 842,366 105,483 14.31 12,495 5.35 0.0085
2014-05-15 2014-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 736,883 -319,694 -30.26 11,861 20.21 0.0084
2014-02-24 2013-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 1,056,577 -332,739 -23.95 9,867 -37.26 0.0071
2014-02-18 2013-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,056,577 9,867
2013-11-18 2013-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,389,316 1,389,316 15,726 0.0116
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-05-15 2015-03-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-13 2014-12-31 13F NEUROCRINE BIOSCIENCES COM Call 1,076 53.71 24 140.00 n/a n/a n/a
2014-11-14 2014-09-30 13F NEUROCRINE BIOSCIENCES COM Call 700 40.00 10 42.86 n/a n/a n/a
2014-08-15 2014-06-30 13F NEUROCRINE BIOSCIENCES COM Call 500 138.10 7 n/a n/a n/a
2014-05-15 2014-03-31 13F NEUROCRINE BIOSCIENCES COM Call 210 5.53 0 n/a n/a n/a
2013-11-18 2013-09-30 13F NEUROCRINE BIOSCIENCES COM Call 199 0 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-05-15 2015-03-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-13 2014-12-31 13F NEUROCRINE BIOSCIENCES COM Put 200 4 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.